News

Isoxazoles are believed to increase insulin production in human pancreas cells no longer able to produce insulin and may represent a new approach to developing treatments for both

Astex will now have no further obligation to conduct additional research work on the program. This decision follows on from the review and rationalization of Astex’s internal pipeline

Ganetespib is a non-ansamycin inhibitor of Hsp90, which is a key facilitator of cancer cell growth and survival. Ganetespib is now being studied in combination with docetaxel in

The pharmaceutical company has also adopted OneKey, the globally comprehensive healthcare professional (HCP) database, and Analyzer for dynamic reporting and actionable analytics. Cegedim’s Mobile Intelligence is believed to

According to the company, the joint solutions are expected to simplify and accelerate the use of new-genermaration mass spectrometry technologies. As per the collaboration, AB SCIEX is combining

Ibudilast demonstrated significant efficacy in a model of post-TBI anxiety, one of the most common disorders caused by TBI. A short course of systemic ibudilast administered over a

The objectives of double-blinded, randomized trial, are to assess the efficacy, local tolerability and safety of DPK-060 ear drops in infections caused by bacterial or fungal pathogens. The

Nobelpharma developed Fostoin in Japan. It will be marketed by Eisai and co-promoted by both companies under a previously concluded marketing agreement. Fostoin is a water-soluble prodrug of

According to the company, the restructuring will strengthen its competitive position in light of loss of Diovan patent and announces charge for Rasilez/Tekturna. The US General Medicines restructuring